Skip to main content
OpenTrials

Clinical trial condition

Inflammation

Explore clinical trials studying Inflammation. Study availability and eligibility vary by location and protocol.

2,756 public trials 390 recruiting studies
Refine in advanced search Browse all conditions

Inflammation trial results

Recruiting

Aminoglycosides in Early Sepsis

NCT06712641

Conditions
Infections, Inflammation, Pathologic Processes, +3 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Lovisenberg Diakonal Hospital Oslo, Norway
  • St. Olav's Hospital Trondheim, Norway
  • Akershus University Hospital Lørenskog, Norway
View Trial Details
Recruiting

Early Norepinephrine Administration and Rapid Dose Adjustment

NCT07343206

Conditions
Cardiovascular Diseases, Hypotension, Infections, +9 more
Locations
  • Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok Noi, Bangkok, Thailand
  • Kalasin Hospital Kalasin, Changwat Kalasin, Thailand
  • Khon Kaen hospital Khon Kaen, Changwat Khon Kaen, Thailand
  • Udon Thani Hospital Udon Thani, Changwat Udon Thani, Thailand
View Trial Details
Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

NCT05972135

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +18 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
View all 17 locations
View Trial Details
Recruiting

Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy

NCT05905328

Conditions
Cytokine Release Syndrome, Inflammation, Pathologic Processes, +3 more
Locations
  • University of California, Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Duke Cancer Institute Durham, North Carolina, United States
View Trial Details

Related conditions